Select Page

The latest report on Epinephrine Autoinjector Market (by dosage (0.15 mg epinephrine autoinjector, and others) and end-user (hospital, clinics and individual)) provides complete and deep insights into the market dynamics and growth of epinephrine autoinjector. Latest information on market risks, industry chain structure epinephrine autoinjector cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential epinephrine autoinjector growth factors. According to report, the global epinephrine autoinjector market is projected to grow at a CAGR of 13.8% over the forecast period of 2018-2024.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Epinephrine autoinjectors are hand-held medical devices used by those who have severe allergies. Epinephrine injections are commonly used against life-threatening allergic reactions caused by stings, insect bites or medications. Epinephrine injections are available as a prefilled automatic injection device with the hormone in the liquid form. The major factors contributing to the growth of the epinephrine autoinjectors include the growing prevalence of allergies, demand for autoinjectors instead of conventional syringes and increased focus of the major leading players towards the development of chlorofluorocarbon (CFC) free epinephrine auto-injectors. However, a high cost of autoinjectors and regulatory hurdles can hinder the epinephrine growth opportunities.

Moreover, Patient’s assistance programs carried out for an uninsured person, continuous product modification and demand for automatic injection devices to further create growth opportunities for the epinephrine autoinjectors market.

North America Has the Largest Market Share in the Epinephrine Autoinjectors Market

North America has the largest market share in the epinephrine autoinjectors market on account of improved healthcare infrastructure, adoption of high-cost autoinjectors rather in contrast to conventional injecting methods. Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to rising number of people afflicted with various allergies and increasing awareness about epinephrine autoinjectors among the end-users.

Get this Section as a Free Customization in the Report along with 30% Discount on the Study:

“We have Decided to Extend our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Global on Epinephrine Autoinjector Market Amidst COVID-19.”

Segments in the Epinephrine Autoinjector Industry

The report on the global epinephrine autoinjector market covers segments such as, dosage and end-user.  On the basis of dosage, the global epinephrine autoinjector market is categorized into 0.15 mg epinephrine autoinjector, 0.3 mg epinephrine autoinjector and 0.5 mg epinephrine autoinjector. On the basis of end-user, the global epinephrine autoinjector market is categorized into hospital, clinics and individuals.

Key Players in the Epinephrine Autoinjector Industry

The report provides profiles of the companies in the global epinephrine autoinjector market such as, Amedra Pharmaceuticals LLC, Mylan Inc., ALK Abello, Sanofi SA, Lincoln Medical Ltd, Teva pharmaceuticals Ltd, Antares Pharma Inc. and Hospira Inc.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the epinephrine autoinjector.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.